GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Gross Profit

Stella Diagnostics (Stella Diagnostics) Gross Profit : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Gross Profit?

Stella Diagnostics's gross profit for the three months ended in Sep. 2023 was $0.00 Mil. Stella Diagnostics's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Stella Diagnostics's gross profit for the three months ended in Sep. 2023 was $0.00 Mil. Stella Diagnostics's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Stella Diagnostics's Gross Margin % for the quarter that ended in Sep. 2023 was N/A%.

Stella Diagnostics had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


Stella Diagnostics Gross Profit Historical Data

The historical data trend for Stella Diagnostics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Gross Profit Chart

Stella Diagnostics Annual Data
Trend
Gross Profit

Stella Diagnostics Quarterly Data
Sep22 Sep23
Gross Profit - -

Competitive Comparison of Stella Diagnostics's Gross Profit

For the Diagnostics & Research subindustry, Stella Diagnostics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Diagnostics's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Gross Profit distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Gross Profit falls into.



Stella Diagnostics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Stella Diagnostics's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Stella Diagnostics's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Stella Diagnostics's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Stella Diagnostics  (OTCPK:SLDX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Stella Diagnostics had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


Stella Diagnostics Gross Profit Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus